01—Abstract
Summary
Summary of the 10-Q filed May 5, 2022. Cited figures are marked; the original filing is the authoritative source.
Ecolab Inc. reported its first quarter 2022 results, showcasing a 13% increase in reported net sales to $3.3 billiona, driven by a 16% rise in fixed currency sales.
This growth was primarily fueled by strong performance across its Global Industrial, Institutional & Specialty, and Healthcare & Life Sciences segments, where accelerating pricing and volume increases helped offset rising delivered product costs. Despite top-line growth, reported operating income declined by 14% to $254.5 millionb, and net income attributable to Ecolab decreased by 11% to $171.9 million, largely due to significant "special (gains) and charges" totaling $77.0 million. These charges included $27.6 million related to the fair value step-up in acquired inventory from the Purolite acquisition and $18.0 million for Russia/Ukraine charges.
Excluding these special charges and discrete tax items, adjusted operating income saw a slight increase of 1% and adjusted net income attributable to Ecolab grew by 1%. Adjusted diluted Earnings Per Share (EPS) rose 1% to $0.82c.
The company's liquidity remains strong with ample credit facilities, though cash and cash equivalents decreased to $99.4 milliond from $359.9 million at the end of 2021, mainly due to increased share repurchases and capital expenditures. Investors should monitor the impact of ongoing cost inflation, supply chain challenges, and geopolitical risks on future profitability.
02—Key points
Key Highlights
- Net sales increased by 13% to $3.3 billion, with fixed currency sales up 16%, driven by pricing and volume across key segments.
- Reported operating income decreased by 14% to $254.5 million due to significant "special (gains) and charges."
- Net income attributable to Ecolab fell 11% to $171.9 million, impacted by $77.0 million in special charges, including inventory step-up from the Purolite acquisition and Russia/Ukraine related costs.
- Adjusted diluted EPS increased by 1% to $0.82, excluding special charges and discrete tax items, indicating underlying operational improvements.
- Gross margin compressed to 36.5% (adjusted 38.1%) from 40.7% (adjusted 41.3%) due to higher delivered product costs outpacing pricing increases.
- Cash provided by operating activities decreased by $125 million to $170.1 million, primarily due to increased working capital needs.
- Share repurchases increased significantly to $262.1 million in the quarter, compared to $61.8 million in the prior year period.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2022, Ecolab Inc. kept $0.05.
- Revenue$3.27B100.0%
- Cost of revenue−$2.07B63.5%
- Gross profit$1.19B36.5%
- Operating costs−$938.8M28.7%
- Operating income$254.5M7.8%
- Interest, other & tax−$82.6M2.5%
- Net income$171.9M5.3%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2022filed May 5, 2022Financial Statements
Q1 FY2022 against Q1 FY2021
| Line item | Q1 FY2022Q1 FY2021 | Change |
|---|---|---|
| Revenue | $3.27B$2.88B | +13.2% |
| Cost of Revenue | $2.07B$1.71B | +21.1% |
| Gross Profit | $1.19B$1.17B | +1.7% |
| SG&A Expenses | $914.70M$862.90M | +6.0% |
| Operating Income | $254.50M$297.30M | −14.4% |
| Interest Expense | $55.10M$53.80M | +2.4% |
| Net Income | $171.90M$196.50M | −12.5% |
| EPS (Basic) | $0.60$0.68 | −11.8% |
| EPS (Diluted) | $0.60$0.67 | −10.4% |
| Shares Outstanding (Basic) | 286.20M286.00M | +0.1% |
| Shares Outstanding (Diluted) | 288.10M288.80M | −0.2% |
05—Questions
Frequently Asked Questions
What was the primary driver of the increase in net sales?
The primary driver of the 13% increase in reported net sales to $3.3 billion was a 16% rise in fixed currency sales. This growth was fueled by strong performance across Ecolab's Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments, supported by accelerating pricing strategies and increased volumes.
Why did operating income and net income decrease despite higher sales?
Operating income decreased by 14% and net income attributable to Ecolab fell by 11% primarily due to significant 'special (gains) and charges' amounting to $77.0 million. These charges included $27.6 million for the fair value step-up in acquired inventory related to the Purolite acquisition and $18.0 million for charges associated with Russia/Ukraine operations. Excluding these items, adjusted operating income and adjusted net income showed modest year-over-year growth.
How is Ecolab addressing inflationary pressures and supply chain challenges?
Ecolab is implementing accelerating pricing strategies and has begun introducing energy-related surcharges to offset higher delivered product costs and raw material inflation. The company expects its pricing actions, coupled with continued volume growth and cost savings initiatives, to mitigate the impact of these inflationary pressures.
What is the company's financial position and liquidity outlook?
Ecolab maintains a strong liquidity position with a $2.0 billion revolving credit facility and significant cash on hand, although cash and cash equivalents decreased to $99.4 million from $359.9 million due to increased share repurchases and capital expenditures. The company expects to fund its foreseeable cash requirements through operating activities and existing borrowing capacity.
06—Continue